TrademarkDir
LOARGYS
LIVE

Serial Number

88627216

Owner

Aeglea BioTherapeutics, Inc.

Attorney

Christopher M. Kindel

First Use Date

Mar 7, 2023

Filing Date

Sep 23, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

LOARGYS Trademark

Serial Number: 88627216 • Registration: 7031345

LOARGYS is a trademark filed by Aeglea BioTherapeutics, Inc. on September 23, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Aeglea BioTherapeutics, Inc. (9 trademarks)

Austin, TX 78746

Entity Type: 03

Immedica Pharma AB (5 trademarks)

Norrtullsgatan 15

Entity Type: 09

Trademark Details

Filing Date

September 23, 2019

Registration Date

April 18, 2023

First Use Anywhere

March 7, 2023

First Use in Commerce

March 7, 2023

Published for Opposition

April 14, 2020

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 6, 2023 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 18, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 18, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 11, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 10, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 10, 2023 SUPC
USE AMENDMENT FILED
Mar 8, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 8, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 29, 2022 EXRA
SOU EXTENSION 5 GRANTED
Dec 28, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 28, 2022 AITU
SOU EXTENSION 5 FILED
Dec 9, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 9, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2022 EXRA
SOU EXTENSION 4 GRANTED
Apr 29, 2022 EX4G
SOU EXTENSION 4 FILED
Apr 29, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 29, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 10, 2021 EXRA
SOU EXTENSION 3 GRANTED
Dec 8, 2021 EX3G
SOU EXTENSION 3 FILED
Dec 8, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 8, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jun 8, 2021 EX2G
SOU EXTENSION 2 FILED
Jun 8, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 8, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2020 EXRA
SOU EXTENSION 1 GRANTED
Dec 3, 2020 EX1G
SOU EXTENSION 1 FILED
Dec 3, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 3, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 9, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 2, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 23, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 23, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 23, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2019 NWOS
NEW APPLICATION ENTERED
Sep 26, 2019 NWAP

Related Trademarks

More from this Owner

IMMEDICA

IMMEDICA

IMMEDICA

IMMEDICA

IMMEDICA

IMMEDICA

IMMEDICA

IMMEDICA

SPYRE THERAPEUTICS

SPYRE THERAPEUTICS

SPYRE THERAPEUTICS logo

SPYRE THERAPEUTICS